Quantcast
Channel: Peter Trayhurn Blog
Viewing all articles
Browse latest Browse all 937

Circulating tumor cells EXCELLENT result

$
0
0

My very dear friend and mentor Dr he in rein Wald invited me as a guest to his amazing conference at Fulda.

Here is The program that You Are Missing Out on.

I raced out shopping as heinz said to look good. I thought black for remembrance.  I was hugged by heinz and he said you look amazing. I do scrub up well. The kind sales assistants fitted me out nicely.

I used too look like the homeless I love and slept with. It's getting cold and snowing now.

But I play the super hero survivor, I have story after story. These very fine doctors lead by passion and integrity and curiosity.  Somehow heinz brings them the best from USA.  Some of the cream of the crop of ketogenic gurus .

For dessert I have a big everest cream and coffee. I take it to the speakers table and tell il2 crp basal temp stories of the mayo clinic and a clever oz scientist

I preach my gospel to all the conference speakers.  They are enthused but one by one they drop off.

Until it's just Dr John,  he is a gifted Dr and scientist . Humble and sincere. He asks perpetrating questions I explain it all. Again he listens. I share my joy of life in the science of my success.

Another top scientist listens and learns. It's late I'm the last one. Off to do enema, dressed to kill. Looking great and all alone in the junior suite. My cancer stories such a good pickup lines.

I'm tired enema and sleep.

But I do my 2nd shot il2 6000000units and some micro veda life

http://www.clinlabnavigator.com/carcinoembryonic-antigen-cea.html

See the report.

https://drive.google.com/file/d/0B10BiJHPKeH8VTNqUFUyRHk1QkNUWDlGa1BEUndMcDZYVk9V/view?usp=docslist_api

I have good talk Dr paccman about assessment. We do further tests focusing immune system. But these results excellent. 

November 24-25, 2015, Concert Hall Felix Meritis, Keizersgracht 324, Amsterdam, The Netherlands

 

 Home

 Program

 Information

 Venue

 Registration

 Abstract

 Sponsors

 

 

 

 

 

 Program

Scientific Program

 

List of confirmed Speakers:

 

Stéphane Ascarateil, Paris, France

Roy Bicknell, Birmingham, United Kingdom

Tanja de Gruijl, Amsterdam, Netherlands

Elisabeth Huijbers, Amsterdam, Netherlands

Lars Hellman, Uppsala, Sweden

Lars Holmgren, Stockholm, Sweden

Yvette van Kooyk, Amsterdam, Netherlands

Lena Kranz, Mainz, Germany

Cornelis Melief, Leiden, Netherlands

Anna-Karin Olsson, Uppsala, Sweden

Michael Platten, Heidelberg, Germany

Jolanda de Vries, Nijmegen, Netherlands

Madelon Wentink, Amsterdam, Netherlands

Laurence Zitvogel, Paris, France

 

Click here for a printer friendly version of the program

 

Tuesday Afternoon, November 24th, 2015

 

 

13.30-14.00

Registration

 

 

14.00-14.15

Opening by Arjan Griffioen (Amsterdam)

 

 

Session 1

 Vaccination strategies

 

 

 

Chair: Arjan Griffioen (Amsterdam, Netherlands)

 

 

 

14.15-14.45

Cornelis Melief

(Leiden, The Netherlands)

Treatment of cancer by therapeutic vaccines requires combination treatment

 

 

 

14.45-15.15

Stephane Ascarateil

(Paris, France)

Characteristics of adjuvants for therapeutic cancer vaccines

 

 

 

15.15-15.30

Frederica Ricardo

(Turin, Italy)

DNA vaccination against human

CSPG4 for the treatment of malignant

melanoma: a comparative oncology

trial in dog

 

 

15.30-16.00

Coffee/tea break

 

 

 

16.00-16.30

Lena Kranz

(Mainz, Germany)

 A liposome-based vaccination platform for the treatment of cancer

 

 

 

16.30-16.45

Evelien Smits

(Antwerp, Belgium)

Vaccination with WT1 mRNA-

electroporated dendritic cells as

postremission treatment can avoid or

delay relapse in acute myeloid

leukemia: phase II study with 30 patients

 

 

 

16.45-17.00Rein Verbeke

(Ghent, Belgium)

Immunogenic mRNA nanoparticles for

dendritic cell-based cancer

vaccination

   

17.00-18.00

Opening mixer

 

.

 

 

 

Wednesday Morning, November 25th, 2015

 

 

Session 2

Vaccination targeting the vasculature

 

 

 

Chair: Anna-Karin Olsson, (Uppsala, Sweden)

 

 

 

09.00-09.30

Michael Platten

(Heidelberg, Germany)

Immunotherapeutic options for brain tumors

 

 

 

09.30-10.00

Anna-Karin Olsson

(Uppsala Sweden)

Targeting tumor vessels by therapeutic vaccination

 

 

 

10.00-10.30

Lars Holmgren

(Stockholm, Sweden)

Targeting novel endothelial junction proteins in cancer

 

 

 

10.30-11.00

Coffee Break

 

 

 

11.00-11.30

Elisabeth Huijbers

(Amsterdam, The Netherlands)

The quest for targets in the tumor vasculature – enhanced vaccination strategies

 

 

 

11.30-12.00

Roy Bicknell

(Birmingham, UK)

Robo4 vaccines induce antibodies that retard tumor growth

 

 

 

12.00-12.30

Madelon Wentink

(Amsterdam, The Netherlands)

hVEGF26-104/RFASE: An angiostatic vaccine targeting VEGF

 

 

12.30-13.45

Lunch

  

Wednesday Afternoon, November 25th, 2015

 

 

Session 3

Promising targets and adjuvants

 

 

 

Chair: Michael Platten (Heidelberg, Germany)

 

 

 

13.45-14.15

Yvette van Kooyk

(Amsterdam, The Netherlands)

Glycan-based DC-SIGN targeting to enhance antigen cross-presentation in anticancer vaccines.

 

 

 

14.15-14.45

Lars Hellman

(Uppsala, Sweden)

Vaccines targeting self-antigens: mechanisms and efficacy-determining parameters.

 

 

 

14.45-15.15

Laurence Zitvogel

(Paris, France)

Gut microbiome and cancer therapeutics: a new arena

 

 

15.15-15.45

Tea Break

 

 

 

15.45-16.15

Jolanda de Vries

(Nijmegen, Netherlands)

Harnessing adaptive immune responses  in hereditary cancer

 

 

 

16.15-16.45

Tanja de Gruijl

(Amsterdam, The Netherlands)

Fighting local immune suppression – improving the odds for cancer vaccination

 

 

 

16.45-17.00

Sophie Dusoswa

(Amsterdam, The Netherlands)

Turning tumor glycans into anti-cancer

vaccines

17.00-17.15

Julia Femel

(Uppsala, Sweden)

A therapeutic cancer vaccine against

galectin-1

 

 

 

 

 

 

 

 

 

 

 

 

 

  X's


Viewing all articles
Browse latest Browse all 937

Trending Articles